How well does the cough syrup help a recent cough?
Part of Infections, Lungs & breathing clinical trials.
This study looks at how well a cough syrup called SIROPSEDAL works in real life for people with a recent cough. If you join, you'll just take the syrup as prescribed and check in after about a week to see how you're doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 1 year old or older.
- You have a cough that started less than 10 days ago and is bothersome enough (score higher than 40 on a 100-point scale).
- Your doctor prescribed the study syrup (SIROPSEDAL) on their own, not just to join the study.
- You do not need to be admitted to the hospital.
- You are not currently taking certain medicines (like ACE inhibitors, steroids, antibiotics, cough suppressants, antihistamines) or using a nebulizer, and haven't in the last 3 days.
- You do not have asthma or COPD, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a nasal spray called RHINOSEDAL works for people whose nose suddenly gets blocked, such as from a cold, allergies, or sinus trouble. It aims to see if the spray helps relieve the blockage within 48 hours of it starting.
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
This study tests a combination medicine containing pain reliever, caffeine, and allergy medication to help ease nasal congestion and other cold or flu symptoms. You'd take the medicine for a short period and report how well it works.
This study tests treatments for the common cold, sinus pain, or sore throat caused by a virus. It compares different options to see which works best for reducing symptoms like runny nose, congestion, and cough.
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
Hear when a new Upper Respiratory Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.